Intersection of immune and oncometabolic pathways drives cancer hyperprogression during immunotherapy
Gaopeng Li(Second Affiliated Hospital of Zhejiang University), Weiping Zou(University of Michigan)
Cited by 145
Related Papers
T cell anergy, exhaustion, senescence, and stemness in the tumor microenvironment
|Current Opinion in Immunology|2013|740
Host expression of PD-L1 determines efficacy of PD-L1 pathway blockade–mediated tumor regression
|Journal of Clinical Investigation|2018|598
Bone Marrow Is a Reservoir for CD4+CD25+ Regulatory T Cells that Traffic through CXCL12/CXCR4 Signals
|Cancer Research|2004|463
A guideline on the molecular ecosystem regulating ferroptosis
|Nature Cell Biology|2024|251
Tissue-resident memory T cells in tumor immunity and immunotherapy
|The Journal of Experimental Medicine|2021|218